Skip to main content

Published locations for FDA approves elotuzumab with pom/dex in refractory myeloma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves elotuzumab with pom/dex in refractory myeloma

User login

  • Reset your password
  • /content/fda-approves-elotuzumab-pom/dex-refractory-myeloma
  • /hematologynews/article/183939/multiple-myeloma/fda-approves-elotuzumab-pom/dex-refractory-myeloma
  • /oncologypractice/article/183939/multiple-myeloma/fda-approves-elotuzumab-pom/dex-refractory-myeloma
  • /hematology-oncology/article/183939/multiple-myeloma/fda-approves-elotuzumab-pom/dex-refractory